Latest Research & News
By Al Qureiyeh On October 22, 202601:00 PM Eastern
I'd add to Berkshire Hathaway, now a "B+" BUY, rather than buy Tesla for a merger.
By Sean Brodrick On October 22, 202611:45 AM Eastern
You have 3 ways to lower your insurance bill. And one fund to profit from it.
By Marija Matic On October 22, 202610:55 AM Eastern
A major web security threat has sparked fear. But the blockchain keeps your crypto safer than you think.
Supercycle Investor
Subscription
By Sean Brodrick On October 22, 202610:35 AM Eastern
Hot inflation, 5% Treasury yields, $110 oil, AI debt fears and midterm uncertainty are holding back the usual Q4 rally. Here’s what could change that.
By Sandeep Kaur On October 22, 202609:45 AM Eastern
Weekly Institutional Crypto Briefing
By Michael A. Robinson On October 22, 202609:35 AM Eastern
Plus, close three more positions ahead of your next issue.
By Sean Brodrick On October 22, 202607:00 AM Eastern
Same Weiss Sell rating, different risk. Here’s how five debt-heavy neoclouds compare on debt, cash and financing.
By Marija Matic On October 21, 202605:39 PM Eastern
Your DeFi portfolio is still going strong even as legacy digital vulnerabilities come to light.
By Mark Gough On October 21, 202604:00 PM Eastern
Microsoft and other big names are pushing back. But the long-term crypto opportunity may be far from over.
By Al Qureiyeh On October 21, 202601:20 PM Eastern
I'd buy Bristol-Myers Squibb, a "B-" BUY that pays about 4% while you wait.